On Dec. 21, Apple Watch Series 9 and Ultra 2 online sales will be paused, while in-store sales of those products will halt on Dec. 24, according to the publication. This is due to a patent dispute the tech giant has with electronics company Masimo.
Masimo said that the Apple Watch blood oxygen sensor feature was created by their company, and in October, the International Trade Commission determined that Apple had infringed upon Masimo patents, requiring the cessation of sales for the devices that violated these patents.
The patents pertain to the method used by the watches to measure an individual’s blood oxygen saturation.
According to the publication, a presidential review of that order is now underway.
“While the review period will not end until Dec. 25, Apple is preemptively taking steps to comply should the ruling stand,” Apple told the publication in a statement.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
